These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32618245)

  • 21. Mass Drug Administration With Dihydroartemisinin-piperaquine and Malaria Transmission Dynamics in The Gambia: A Prospective Cohort Study.
    Mwesigwa J; Achan J; Affara M; Wathuo M; Worwui A; Mohammed NI; Kanuteh F; Prom A; Dierickx S; di Tanna GL; Nwakanma D; Bousema T; Drakeley C; Van Geertruyden JP; D'Alessandro U
    Clin Infect Dis; 2019 Jul; 69(2):278-286. PubMed ID: 30304511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.
    Gerardin J; Eckhoff P; Wenger EA
    BMC Infect Dis; 2015 Mar; 15():144. PubMed ID: 25887935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reactive, self-administered malaria treatment against asymptomatic malaria infection: results of a cluster randomized controlled trial in The Gambia.
    Okebe J; Dabira E; Jaiteh F; Mohammed N; Bradley J; Drammeh NF; Bah A; Masunaga Y; Achan J; Muela Ribera J; Yeung S; Balen J; Peeters Grietens K; D'Alessandro U
    Malar J; 2021 Jun; 20(1):253. PubMed ID: 34098984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the operational challenges in implementing reactive screen-and-treat and implications of reactive case detection strategies for malaria elimination in a region of low transmission in southern Zambia.
    Searle KM; Hamapumbu H; Lubinda J; Shields TM; Pinchoff J; Kobayashi T; Stevenson JC; Bridges DJ; Larsen DA; Thuma PE; Moss WJ;
    Malar J; 2016 Aug; 15(1):412. PubMed ID: 27527347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Large-scale Artemisinin-Piperaquine Mass Drug Administration With or Without Primaquine Dramatically Reduces Malaria in a Highly Endemic Region of Africa.
    Deng C; Huang B; Wang Q; Wu W; Zheng S; Zhang H; Li D; Feng D; Li G; Xue L; Yang T; Tuo F; Mohadji F; Su XZ; Xu Q; Wu Z; Lin L; Zhou J; Yan H; Bacar A; Said Abdallah K; Kéké RA; Msa Mliva A; Mohamed M; Wang X; Huang S; Oithik F; Li XB; Lu F; Fay MP; Liu XH; Wellems TE; Song J
    Clin Infect Dis; 2018 Nov; 67(11):1670-1676. PubMed ID: 29846536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving the efficiency of reactive case detection for malaria elimination in southern Zambia: a cross-sectional study.
    Bhondoekhan FRP; Searle KM; Hamapumbu H; Lubinda M; Matoba J; Musonda M; Katowa B; Shields TM; Kobayashi T; Norris DE; Curriero FC; Stevenson JC; Thuma PE; Moss WJ;
    Malar J; 2020 May; 19(1):175. PubMed ID: 32381005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of Subpatent Malaria in a Pre-Elimination Setting in Southern Zambia.
    Kobayashi T; Kanyangarara M; Laban NM; Phiri M; Hamapumbu H; Searle KM; Stevenson JC; Thuma PE; Moss WJ; For The Southern Africa International Centers Of Excellence For Malaria Research
    Am J Trop Med Hyg; 2019 Feb; 100(2):280-286. PubMed ID: 30526744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multiphase program for malaria elimination in southern Mozambique (the Magude project): A before-after study.
    Galatas B; Saúte F; Martí-Soler H; Guinovart C; Nhamussua L; Simone W; Munguambe H; Hamido C; Montañà J; Muguande O; Maartens F; Luis F; Paaijmans K; Mayor A; Bassat Q; Menéndez C; Macete E; Rabinovich R; Alonso PL; Candrinho B; Aide P
    PLoS Med; 2020 Aug; 17(8):e1003227. PubMed ID: 32797101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials.
    Phommasone K; van Leth F; Peto TJ; Landier J; Nguyen TN; Tripura R; Pongvongsa T; Lwin KM; Kajeechiwa L; Thwin MM; Parker DM; Wiladphaingern J; Nosten S; Proux S; Nguon C; Davoeung C; Rekol H; Adhikari B; Promnarate C; Chotivanich K; Hanboonkunupakarn B; Jittmala P; Cheah PY; Dhorda M; Imwong M; Mukaka M; Peerawaranun P; Pukrittayakamee S; Newton PN; Thwaites GE; Day NPJ; Mayxay M; Hien TT; Nosten FH; Cobelens F; Dondorp AM; White NJ; von Seidlein L
    PLoS One; 2020; 15(2):e0228190. PubMed ID: 32023293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mass drug administration should be implemented as a tool to accelerate elimination: against.
    Mendis K
    Malar J; 2019 Aug; 18(1):279. PubMed ID: 31438943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mass drug administration for malaria.
    Poirot E; Skarbinski J; Sinclair D; Kachur SP; Slutsker L; Hwang J
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD008846. PubMed ID: 24318836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamics of malaria transmission and susceptibility to clinical malaria episodes following treatment of Plasmodium falciparum asymptomatic carriers: results of a cluster-randomized study of community-wide screening and treatment, and a parallel entomology study.
    Tiono AB; Guelbeogo MW; Sagnon NF; Nébié I; Sirima SB; Mukhopadhyay A; Hamed K
    BMC Infect Dis; 2013 Nov; 13():535. PubMed ID: 24215306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of artesunate-mefloquine fixed-dose combination in malaria transmission in Amazon basin communities.
    Santelli AC; Ribeiro I; Daher A; Boulos M; Marchesini PB; dos Santos RL; Lucena MB; Magalhães I; Leon AP; Junger W; Ladislau JL
    Malar J; 2012 Aug; 11():286. PubMed ID: 22905900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrocardiographic Safety of Repeated Monthly Dihydroartemisinin-Piperaquine as a Candidate for Mass Drug Administration.
    Millat-Martínez P; Ila R; Laman M; Robinson L; Karunajeewa H; Abel H; Pulai K; Sanz S; Manning L; Moore B; Bassat Q; Mitjà O
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Operational strategies of anti-malarial drug campaigns for malaria elimination in Zambia's southern province: a simulation study.
    Stuckey EM; Miller JM; Littrell M; Chitnis N; Steketee R
    Malar J; 2016 Mar; 15():148. PubMed ID: 26957364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained Malaria Transmission despite Reactive Screen-and-Treat in a Low-Transmission Area of Southern Zambia.
    Searle KM; Katowa B; Musonda M; Pringle JC; Hamapumbu H; Matoba J; Lubinda M; Shields T; Kobayashi T; Stevenson JC; Norris DE; Thuma PE; Wesolowski A; Moss WJ;
    Am J Trop Med Hyg; 2020 Nov; 104(2):671-679. PubMed ID: 33236715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementing population-based mass drug administration for malaria: experience from a high transmission setting in North Eastern Uganda.
    Mulebeke R; Wanzira H; Bukenya F; Eganyu T; Collborn K; Elliot R; Van Geertruyden JP; Echodu D; Yeka A
    Malar J; 2019 Aug; 18(1):271. PubMed ID: 31399051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mass testing and treatment for malaria followed by weekly fever screening, testing and treatment in Northern Senegal: feasibility, cost and impact.
    Conner RO; Dieye Y; Hainsworth M; Tall A; Cissé B; Faye F; Sy MD; Ba A; Sene D; Ba S; Doucouré E; Thiam T; Diop M; Schneider K; Cissé M; Ba M; Earle D; Guinot P; Steketee RW; Guinovart C
    Malar J; 2020 Jul; 19(1):252. PubMed ID: 32664939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic efficacy of artemether-lumefantrine on treatment of uncomplicated Plasmodium falciparum mono-infection in an area of high malaria transmission in Zambia.
    Hamainza B; Masaninga F; Moonga H; Mwenda M; Chanda-kapata P; Chalwe V; Chanda E; Kamuliwo M; Babaniyi OA
    Malar J; 2014 Nov; 13():430. PubMed ID: 25403945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct parasite populations infect individuals identified through passive and active case detection in a region of declining malaria transmission in southern Zambia.
    Searle KM; Katowa B; Kobayashi T; Siame MNS; Mharakurwa S; Carpi G; Norris DE; Stevenson JC; Thuma PE; Moss WJ;
    Malar J; 2017 Apr; 16(1):154. PubMed ID: 28420399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.